PTC Therapeutics manufactures and commercializes small molecule drugs for the treatment of infectious diseases and neuromuscular disorders.
Business Model:
Revenue: $696.6M
Employees: 1,001-5,000
Address: 100 Corporate Court
City: South Plainfield
State: NJ
Zip: 07080
Country: US
PTC Therapeutics manufactures and commercializes small molecule drugs for the treatment of infectious diseases and neuromuscular disorders.
Contact Phone:
+19082227000
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/20/2013
IPO Valuation:
$322M
Ticker Symbol:
PTCT
IPO Price:
$15/share
Amount Raised:
$126M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2020 | ClearPoint Neuro | Equity | 17.5M |
1/2020 | ClearPoint Neuro | Post-IPO Equity | 0 |
Announced Date | Name | Price |
---|---|---|
5/2020 | Censa Pharmaceuticals | |
10/2019 | BioElectron Technology Corporation | |
7/2018 | Agilis Biotherapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|